BioSpace News Archive

Pelican BioThermal recognized alongside Minnesota manufacturing powerhouses H.B. Fuller, Mercury Mosaics, Smude Enterprises and Starkey Hearing Technologies.

Estimated total sales of HEMOBLAST™ Bellows for the first nine months of 2019 are expected to show strong growth at €2.5 million (compared to €1.5 million for the first half of 2019 and €0.6 million for the full year 2018) and are expected to be on track to achieve the 2019 revenue guidance range of €4.0-€4.5 million

GENFIT, a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases, announces its first half 2019 financial results.

TLC announced the initiation of a Phase III clinical trial (“EXCELLENCE”) to evaluate the efficacy and safety of single as well as repeated doses of TLC599 in patients with osteoarthritis (OA) of the knee.

Partnership combines global CDMO services with industry leading cellular orchestration platform

According to multiple reports, President Donald Trump is set to pick Hahn, a noted radiation oncologist, as the successor to Scott Gottlieb.

To learn more about employment law rights, we interviewed attorney J. Daniel Cole. Daniel provided key insights regarding an organization’s legal obligations and what you can do if you think you are being set up to be fired.

UW-Madison physician researchers Amish Raval, M.D., and Tim Kamp, M.D., Ph.D., have been awarded a U01 Research Project Cooperative Agreement by The National Institutes of Health.

Global Blood Therapeutics, Inc., announced that it will host an Analyst & Investor Day to provide an update to the investment community on the company’s development and commercial strategy for voxelotor for sickle cell disease.

New myTXTL bulk packagings align with volumes required for high-throughput organizations in synthetic biology.